SURI - Simplify Propel Opportunities ETF (USD) (US82889N6242)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Sélectionnez tout Réinitialiser tout

Enregistrer Fermer

(%)

US82889N6242

SURI ISIN

Fonds négociés en bourse (FNB)

Type de fonds

Simplify Asset Management

Fournisseur

valeur liquidative par action

07/02/2023

Date de lancement

4 fois par an

Paiement de dividendes

CEOJLS

CFI

SURI

Ticker

Formed

Status

Equity

Objet d'investissement

Healthcare

Secteur

Global

Géographie

No benchmark

Benchmark

2.54 %

Ratio de coût total

Physical

Méthode de réplication

77,65 mln USD

Actif total du fonds | 23/07/2026

77,65 mln USD

Volume des actits de classe "actions" | 23/07/2026

Non

UCITS

Rendement au 23/07/2026, NYSE Arca

YTD

8,97 %
1M

1,21 %
3M

10,28 %
6M

13,52 %
1Y

42,77 %
3Y

20,88 %
5Y

-
10Y

-

Au prix de la bourse, avec prise en compte des paiements

Dernières données pour

Ajouter à comparer

Cotations (SURI)

Explorer la base de données la plus complète

1 000 000

obligations

100 000

actions

175 910

ETF & Funds

100 000

indices

Suivre votre portefeuille de la manière la plus efficace

Screener d'obligations
liste de surveillance
Excel ADD-IN

Obtenir l'accès

Dynamique des prix

Fund profile

The Simplify Propel Opportunities ETF is an actively managed ETF that seeks long-term capital appreciation by investing in a portfolio comprised primarily of global biotech, pharma, health care technology, and life science companies

SURI profile

The Simplify Propel Opportunities ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The Simplify Asset Management fund’s base currency is USD and the share class was registered 07.02.2023 with unique ISIN - US82889N6242. Main exchange is NYSE Arca and ticker symbol is SURI. The total expense ratio is 2.54%. The Simplify Propel Opportunities ETF (USD) pays dividends 4 time(s) per year.

Structure SURI au 22/07/2026

Exporter la structure dans Excel

Titre	Valeur
PLAINS GP HLDGS L P	42,98%
ACHIEVE LIFE SCIENCES INC USD 0.001	11,65%
MILESTONE PHARMACEUTICALS INC NPV	5,14%
DELCATH SYS INC USD 0.01	4,22%
ACHIEVE LIFE SCIENCES I WTS 30JUN30	4,12%
PHATHOM PHARMACEUTICALS USD 0.0001	3,76%
CORCEPT THERAPEUTICS INC USD 0.001	3,1%
CELLDEX THERAPEUTICS INC USD 0.001	2,38%
ABEONA THERAPEUTICS INC USD 0.01	2,29%
Cash	1,97%
INVENTIVA SA NPV ADR	1,83%
COMPASS PATHWAYS PLC USD 0.008 ADR	1,76%
KYVERNA THERAPEUTICS IN USD 0.00001	1,74%
LEONABIO INC USD 0.0001	1,45%
AQUESTIVE THERAPEUTICS IN USD 0.001	1,42%
ARTIVA BIOTHERAPEUTICS I USD 0.0001	1,31%
Telesat, 5.625% 6dec2026, USD	1,16%
PALISADE BIO INC USD 0.01	1,06%
ZEVRA THERAPEUTICS INC USD 0.0001	1,05%
ORCHESTRA BIOMED HLDGS I USD 0.0001	1,03%
OCULAR THERAPEUTIX INC USD 0.0001	0,9%
ACHIEVE LIFE SCIENCES WTS	0,89%
EYEPOINT INC	0,63%
IMMUNIC INC USD 0.0001	0,6%
AKERO THERAPEUTICS INC CVR	0,55%
UPSTREAM BIO INC USD 0.001	0,53%
SAB BIOTHERAPEUTICS INC USD 0.0001	0,48%
Chinook Therapeutics, ord.	0%
EIGER BIOPHARMACEUTICALS USD 0.0001	0%
WTS - MILESTONE PHARMACEUTICALS INC SERIES B	0%
WTS - TENAYA THERAPEUTICS INC	0%
JASPER THERAPEUTIC WTS	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series J	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series H	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series I	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series K	0%
ALTIMMUNE INC	0%

Montrer tout Cacher

Autres - %

Autres ETF et fonds de ce fournisseur

ETF et fonds similaires

{{ item.etf.ttl }}

{{ item.nav_usd }} mln
Valeur nette d'actifs

{{ item.expense_ratio }}
Ratio de coût total